HD-OPM Archive
Topics › Cancer

Statin plus sildenafil may block cancer metastasis in preclinical models

Louis Nervegna · Jul 27, 2026 · ♥ 16 reactions · 4 comments · original Facebook post
CancerStatins
AI summary & key facts

A 2026 Cancer Research study found sildenafil (a PDE5 inhibitor) caused cholesterol to accumulate in lysosomes of mouse and human cancer models, limiting cholesterol available to cancer cells and impairing their migration and spread. Combining it with a statin, which blocks cholesterol production, gave stronger anti-metastatic effects than either alone. Louis notes the research is preclinical but promising.

The combination of a statin and a PDE5 inhibitor (like viagra) might protect against cancer metastasis.

The two drugs work together by disrupting cholesterol production and cholesterol transport in cancer cells.

The preclinical research on this looks promising.

Link to journal paper:

PaperPDE5a Inhibition Restricts Cancer Metastasis by Disrupting NPC1 Mediated Cholesterol Trafficking Through a Non canonical cGMP Dependent Pathwayresearchgate.net

Links to press coverage on the study:

medicalxpress.comViagra cancer metastasismedicalxpress.com NewsweekViagra was designed for one thing. A new study points to an unexpected role in cancerResearchers found that Viagra may block cancer's spread by cutting off its cholesterol supply.newsweek.com

#pde5HD #viagraHD #cialisHD #statinsHD #statinscancerHD #cancerHD

Research cited

A 2026 study published in the peer-reviewed journal Cancer Research investigated how PDE5 inhibitors, including sildenafil (Viagra), affect cancer metastasis. Researchers found that sildenafil caused cholesterol to accumulate inside lysosomes in both mouse and human cancer models, reducing the cholesterol available to cancer cells. This disrupted cancer cell migration, mitochondrial energy production, and the ability of cancer cells to spread (metastasize).

The researchers also found that combining sildenafil with statins produced stronger anti-metastatic effects than either treatment alone by blocking both cholesterol transport and cholesterol production. In addition, an analysis of digital health records showed that cancer patients taking sildenafil had significantly improved survival, with a dose-dependent additional survival benefit observed among those taking both sildenafil and statins. The authors concluded that PDE5 inhibition may be a promising strategy to help restrict cancer metastasis, but further clinical studies are needed to confirm these findings.

No photo description available.
← newer: Unavailable shared post tagged taurine and agingolder: Essay on stupidity as an active mechanism, applied to health →